Healthcare Services

A key trend shaping the Cannabinoids Market involves the Innovative Advancements In Fast-Acting Cannabinoids

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Cannabinoids Market Across 2026–2030?

The cannabinoids market has experienced substantial growth in recent years. It is anticipated to increase from $47.03 billion in 2025 to $56.75 billion in 2026, progressing at a compound annual growth rate (CAGR) of 20.7%. The historical expansion of this market can be linked to several key drivers, including the expanding legalization of medical cannabis initiatives, the growing occurrence of chronic pain and cancer requiring treatment, increased receptiveness towards alternative therapies, the broadening of hospital pharmacy distribution channels, and the formulation of standardized cannabinoid products.

The cannabinoids market is projected to undergo significant expansion in the coming years, with its size expected to reach $120.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.7%. This anticipated growth during the forecast period can be attributed to several factors, including the expansion of clinical research into cannabinoids, an increasing demand for pharmaceutical-grade cannabinoid products, greater regulatory clarity developing across various regions, the advancement of cannabinoid-based personalized medicine, and growing investments in infrastructure for cannabinoid manufacturing. Key trends for the forecast period include the increasing medical adoption of cannabinoid-based therapies, a rising demand for CBD-dominant products, the growing utilization of cannabinoids in the management of chronic diseases, the expansion of regulated cannabinoid supply chains, and an enhanced focus on ensuring product standardization and purity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8079&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Cannabinoids Market?

The growing incidence of chronic diseases is anticipated to boost the cannabinoid market. These conditions are defined as illnesses persisting for a year or more, necessitating continuous medical care. A systematic review of randomized controlled trials investigated the efficacy of various cannabinoids, including smoked marijuana, oromucosal extracts of cannabis-based medication, nabilone, dronabinol, and a novel THC analogue, in managing chronic noncancer pain. For example, data from April 2025 by the Centers for Disease Control and Prevention (CDC), a US-based federal agency, revealed that in 2023, around 194 million U.S. adults, or 76.4%, reported experiencing at least one chronic condition. The prevalence figures showed 59.5% for young adults, 78.4% for midlife adults, and 93.0% for older adults. Consequently, the increasing occurrence of chronic diseases is a key factor propelling the expansion of the cannabinoid market.

What Segmentation Levels Are Considered In The Cannabinoids Market?

The cannabinoids market covered in this report is segmented –

1) By Product Type: Cannabidiol, Tetrahydrocannabinol, Cannabinol, Other Product Types

2) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Stores

3) By Application: Medical, Recreational, Industrial Hemp

Subsegments:

1) By Cannabidiol (CBD): Full-Spectrum CBD, Broad-Spectrum CBD, CBD Isolate

2) By Tetrahydrocannabinol (THC): Delta-9 THC, Delta-8 THC

3) By Cannabinol (CBN): CBN Isolate, CBN Oil

4) By Other Product Types: Cannabigerol (CBG), Cannabichromene (CBC)

What Trends Are Projected To Affect The Cannabinoids Market?

Leading firms in the cannabinoids market are prioritizing the creation of novel solutions, including fast-acting cannabinoids, aimed at improving the effectiveness and quickness of therapeutic outcomes. These fast-acting cannabinoids denote formulations of cannabinoids engineered to elicit more rapid therapeutic responses post-ingestion, contrasting with conventional delivery techniques. An example occurred in August 2024 when Rare Cannabinoid, a US-headquartered health and wellness enterprise, introduced Fast-Acting Nano THC + CBC Mood Mints, thereby extending its well-liked mood product range through a novel delivery approach. The mints are formulated to deliver swift effects, enabling consumers to feel the advantages of delta-9-THC and cannabichromene (CBC) within a timeframe of 15 to 30 minutes, which is quicker than the usual 30 to 90 minutes associated with standard edibles. Employing sophisticated nanotechnology, these mints provide versatile dosing choices, catering to both microdosing practices and specific individual requirements.

Which Leading Firms Are Contributing To The Growth Of The Cannabinoids Market?

Major companies operating in the cannabinoids market are The Supreme Cannabis Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC, Tilray Inc., Aurora Cannabis Inc., Curaleaf Holdings Inc., Green Thumb Industries, Verano Holdings, Trulieve Cannabis Corp., Cresco Labs Inc., Cronos Group, TerrAscend Corp., Canopy Growth Corp., Sundial Growers Inc., Decibel Cannabis Company, Auxly Cannabis Group, Red White & Bloom Brands, BZAM Ltd, Delta 9 Cannabis Inc., Jazz Pharmaceuticals PLC, Aphria Inc., Organigram Inc., MediPharm Labs Corp., The Valens GroWorks Inc.

Read the full cannabinoids market report here:

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Which Regions Are Projected To Dominate The Cannabinoids Market In The Coming Years?

North America was the largest region in the cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cannabinoids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8079&type=smp

Browse Through More Reports Similar to the Global Cannabinoids Market 2026, By The Business Research Company

Yeast Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Systemic Aspergillosis And Systemic Candidiasis Global Market Report

https://www.thebusinessresearchcompany.com/report/systemic-aspergillosis-and-systemic-candidiasis-global-market-report

Antifungals Global Market Report

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795